QHSLab, Inc. (USAQ): Total Liabilities
$546.1K
As of 2025-12-31
$375.8K
As of 2026-06-30
-33.8%
3-year compound annual growth
-9.6%
5-year compound annual growth
+1.7%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $546.1K | -77.3% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $2.41M | +17.0% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $2.06M | +9.3% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $1.88M | +35.9% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $1.38M | +52.8% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $906.2K | +98.7% | 2022-04-01, Balance as of period end |
| 2019-12-31 | $456.1K | -14.8% | 2021-03-11, Balance as of period end |
| 2018-12-31 | $535.3K | +8.2% | 2020-02-21, Balance as of period end |
| 2017-12-31 | $494.9K | +2.3% | 2019-03-28, Balance as of period end |
| 2016-12-31 | $483.5K | +5.1% | 2018-08-27, Balance as of period end |
| 2015-12-31 | $460.3K | +11.4% | 2018-08-07, Balance as of period end |
| 2014-12-31 | $413.2K | +10.9% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $372.7K | +23.1% | 2015-04-07, Balance as of period end |
| 2012-12-31 | $302.8K | +29.9% | 2014-05-12, Balance as of period end |
| 2011-12-31 | $233.2K | +49.3% | 2014-02-26, Balance as of period end |
| 2010-12-31 | $156.2K | n/a | 2012-04-12, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| QHSLab, Inc. (USAQ) | 2025-12-31 | $546.1K | -77.3% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $44.20M | +38.0% |
| Femasys Inc (FEMY) | 2025-12-31 | $14.85M | +46.5% |
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $2.80M | +314.7% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $4.92M | +4.9% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $5.72M | +47.7% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $6.65M | +22.4% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $71.64M | +45.6% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $29.51M | +16.5% |
Compare USAQ, OSRH, FEMY, AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗